Impact BioMedical Inc.
IBO | AMEX
$4.05
+$0.25 (+6.58%)
Nov 2, 2026, 10:14 AM ET · Market open
Market Data
Market Cap $34.6M
Enterprise Value $32.46M
Beta 2.73
Average Volume 12.31K
Shares Outstanding (Diluted) 8.54M
Shares Change YoY 784.84%
Institutional Ownership 3.56%
Exchange AMEX
ISIN US45259L3042
Price Performance
Price Change 1M -23.9%
Price Change 3M -26.9%
Price Change 6M -49.5%
Price Change YTD -36.4%
Price Change 1Y -39.7%
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -49.0%
1Y CAGR (ann.) -47.1%
5Y CAGR (ann.) N/A
All-Time CAGR -64.3%
Valuation
PE Ratio -3.09
Forward PE N/A
PEG Ratio -0.02
Forward PEG -0.02
PS Ratio 927.60
Forward PS N/A
PB Ratio 3.02
P/FCF Ratio -63.91
P/Adj. FCF Ratio -62.31
P/OCF Ratio -63.33
EV/Sales 927.31
EV/EBIT -21.02
EV/EBITDA -80.94
EV/FCF -63.89
Earnings Yield -32.4%
FCF Yield -1.6%
Adj. FCF Yield -1.6%
Financial Health
Net Cash $10K
Total Debt $0
Cash & Short-Term Investments $10K
Total Assets $16.75M
Current Ratio 0.16
Quick Ratio 0.13
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -19.45
Altman Z-Score 2.31
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin -1111.4%
Operating Profit Margin -14562.9%
EBITDA Margin -1145.7%
Net Profit Margin 2254.3%
FCF Margin -1451.4%
Adj. FCF Margin -1488.6%
SBC / Revenue 37.1%
SBC Impact (per share) -2.6%
Returns
Return on Assets 4.7%
Return on Equity 13.7%
Return on Invested Capital 14.9%
Return on Capital Employed -34.7%
Return on Tangible Assets 246.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 125.0%
Revenue CAGR 5Y -12.5%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 10.1%
EPS CAGR 5Y -28.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y 34.1%
FCF CAGR 5Y 7.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 7, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-508K
Free Cash Flow $-508K
Adj. Free Cash Flow $-521K
FCF Per Share -$0.06
OCF Per Share -$0.06
OCF/S Ratio -1451.4%
Income Statement
Revenue $35K
Gross Profit $-389K
Operating Income $-5.1M
EBITDA $-401K
Net Income $789K
EPS (Diluted) -$1.23
Revenue / Employee $17.5K
Profit / Employee $394.5K
Employees 2
Add to Watchlist
Select watchlists to add or remove IBO